Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jim Messina
AddedMar 31, 2024
UpdatedMay 31, 2026
Jim Messina

Jim Messina

Board Member, Vectra AI

Crunchbase

Jim Messina's Career

Vectra AI
Vectra AI

San Jose, CA, US

Board Member· Board
PillPack
PillPack

Manchester, NH, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jim Messina's Career

Vectra AI
Vectra AI
Series F$352.5M5802012San Jose, CA, US
Board Member· Board

Leadership at Vectra AI

Bruce ArmstrongBruce ArmstrongBoard Member
Kevin DillonKevin DillonBoard Member
Eric WolfordEric WolfordBoard Member
Brad GillespieBrad GillespieBoard Member
Mark AbeneMark AbeneFounder
Charles GiancarloCharles GiancarloBoard Member
PillPack
PillPack
$93.9M02013Manchester, NH, US
Board Member· Board

Leadership at PillPack

TJ ParkerTJ ParkerCo-Founder
Pravin VaziraniPravin VaziraniBoard Member
David FrankelDavid FrankelBoard Member
Jeff FagnanJeff FagnanBoard Member
George ZacharyGeorge ZacharyBoard Member
Jon KarlenJon KarlenBoard Member

Similar to PillPack

Pills2MePills2MeLas Vegas, NV, USOver-The-Counter, Pharmacy Deliveryest. 2020Pills2MeLas Vegas, NV, US · est. 2020

Pills2Me: Streamlining healthcare with convenient pharmacy delivery for prescriptions and over-the-counter items.

Angel · $366.8k11
NimbleRxNimbleRxRedwood City, CA, USPharmacy, Prescription Deliveryest. 2015NimbleRxRedwood City, CA, US · est. 2015

Tech-driven pharmacy service enhancing access to medications.

Series B · $74.9M115
TruepillTruepillSan Mateo, CA, USHealthcare, Pharmacyest. 2017TruepillSan Mateo, CA, US · est. 2017

API-driven healthcare for seamless patient care, including prescribing, testing, and pharmacy services.

$255.4M
PillDrillPillDrillSan Francisco, CA, USMedication Trackingest. 2013PillDrillSan Francisco, CA, US · est. 2013

PillDrill: A user-friendly medication tracking system, offering reminders, tracking, and connectivity.

Angel · $3M9

People Similar to Jim Messina

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · KakaoChris LiddellChris LiddellBoard Member · AnthropicSara FagenSara FagenCEO · TunnlAnthony ScaramucciAnthony ScaramucciFounder · Oscar CapitalRobert CardilloRobert CardilloBoard Member · Planet LabsRon KlainRon KlainBoard Member · BrainScope CompanyAnthony NunezAnthony NunezCo-Founder · INF Care